FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066214356> ?p ?o ?g. }

• W2066214356 endingPage "868" @default.
• W2066214356 startingPage "862" @default.
• W2066214356 abstract "Parasitic infections caused by Entamoeba histolytica are still major threats against public health, especially in developing countries. Although current therapies exist, the problems associated with parasite resistance and negative side effects make it imperative to search for new therapeutic agents. A systematic scaffold analysis reported herein of a public database containing 474 antiamoebic compounds reveals that benzimidazole is the most active scaffold reported thus far. To gain insights into the antiamoebic activity of novel compounds, the authors report herein the biological activity of 12 compounds, including benzotriazole and indazole derivatives, scaffolds not previously tested against E. histolytica. Compounds with the benzotriazole and indazole scaffolds showed low micromolar activity (IC50 = 0.304 and 0.339 µM) and are more active than metronidazole, which is the drug of choice used for the treatment of amebiosis. The novel compounds have similar properties to approved drugs. Compounds with novel scaffolds represent promising starting points of an optimization program against E. histolytica. Parasitic infections caused by Entamoeba histolytica are still major threats against public health, especially in developing countries. Although current therapies exist, the problems associated with parasite resistance and negative side effects make it imperative to search for new therapeutic agents. A systematic scaffold analysis reported herein of a public database containing 474 antiamoebic compounds reveals that benzimidazole is the most active scaffold reported thus far. To gain insights into the antiamoebic activity of novel compounds, the authors report herein the biological activity of 12 compounds, including benzotriazole and indazole derivatives, scaffolds not previously tested against E. histolytica. Compounds with the benzotriazole and indazole scaffolds showed low micromolar activity (IC50 = 0.304 and 0.339 µM) and are more active than metronidazole, which is the drug of choice used for the treatment of amebiosis. The novel compounds have similar properties to approved drugs. Compounds with novel scaffolds represent promising starting points of an optimization program against E. histolytica." @default.
• W2066214356 created "2016-06-24" @default.
• W2066214356 creator A5041252377 @default.
• W2066214356 creator A5047441507 @default.
• W2066214356 creator A5055524253 @default.
• W2066214356 creator A5086421148 @default.
• W2066214356 date "2011-09-01" @default.
• W2066214356 modified "2023-10-17" @default.
• W2066214356 title "Benzotriazoles and Indazoles Are Scaffolds with Biological Activity against Entamoeba histolytica" @default.
• W2066214356 cites W1966537358 @default.
• W2066214356 cites W1967283249 @default.
• W2066214356 cites W1981474586 @default.
• W2066214356 cites W1992122072 @default.
• W2066214356 cites W2005724145 @default.
• W2066214356 cites W2009313526 @default.
• W2066214356 cites W2018621056 @default.
• W2066214356 cites W2020155551 @default.
• W2066214356 cites W2022747627 @default.
• W2066214356 cites W2039609876 @default.
• W2066214356 cites W2039805951 @default.
• W2066214356 cites W2044609406 @default.
• W2066214356 cites W2057481965 @default.
• W2066214356 cites W2075043416 @default.
• W2066214356 cites W2090442983 @default.
• W2066214356 cites W2098358868 @default.
• W2066214356 cites W2099515703 @default.
• W2066214356 cites W2108335589 @default.
• W2066214356 cites W2131839450 @default.
• W2066214356 cites W2154241593 @default.
• W2066214356 cites W2167115266 @default.
• W2066214356 cites W2174653290 @default.
• W2066214356 cites W2176255757 @default.
• W2066214356 cites W2176516200 @default.
• W2066214356 cites W2214067381 @default.
• W2066214356 cites W2952181316 @default.
• W2066214356 cites W2952662905 @default.
• W2066214356 doi "https://doi.org/10.1177/1087057111414902" @default.
• W2066214356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21821786" @default.
• W2066214356 hasPublicationYear "2011" @default.
• W2066214356 type Work @default.
• W2066214356 sameAs 2066214356 @default.
• W2066214356 citedByCount "47" @default.
• W2066214356 countsByYear W20662143562012 @default.
• W2066214356 countsByYear W20662143562013 @default.
• W2066214356 countsByYear W20662143562014 @default.
• W2066214356 countsByYear W20662143562015 @default.
• W2066214356 countsByYear W20662143562016 @default.
• W2066214356 countsByYear W20662143562017 @default.
• W2066214356 countsByYear W20662143562018 @default.
• W2066214356 countsByYear W20662143562019 @default.
• W2066214356 countsByYear W20662143562020 @default.
• W2066214356 countsByYear W20662143562021 @default.
• W2066214356 countsByYear W20662143562022 @default.
• W2066214356 countsByYear W20662143562023 @default.
• W2066214356 crossrefType "journal-article" @default.
• W2066214356 hasAuthorship W2066214356A5041252377 @default.
• W2066214356 hasAuthorship W2066214356A5047441507 @default.
• W2066214356 hasAuthorship W2066214356A5055524253 @default.
• W2066214356 hasAuthorship W2066214356A5086421148 @default.
• W2066214356 hasBestOaLocation W20662143561 @default.
• W2066214356 hasConcept C178790620 @default.
• W2066214356 hasConcept C185592680 @default.
• W2066214356 hasConcept C21951064 @default.
• W2066214356 hasConcept C2776867272 @default.
• W2066214356 hasConcept C2777844968 @default.
• W2066214356 hasConcept C2778455923 @default.
• W2066214356 hasConcept C2778484023 @default.
• W2066214356 hasConcept C2780591553 @default.
• W2066214356 hasConcept C71240020 @default.
• W2066214356 hasConcept C86803240 @default.
• W2066214356 hasConcept C89423630 @default.
• W2066214356 hasConcept C98274493 @default.
• W2066214356 hasConceptScore W2066214356C178790620 @default.
• W2066214356 hasConceptScore W2066214356C185592680 @default.
• W2066214356 hasConceptScore W2066214356C21951064 @default.
• W2066214356 hasConceptScore W2066214356C2776867272 @default.
• W2066214356 hasConceptScore W2066214356C2777844968 @default.
• W2066214356 hasConceptScore W2066214356C2778455923 @default.
• W2066214356 hasConceptScore W2066214356C2778484023 @default.
• W2066214356 hasConceptScore W2066214356C2780591553 @default.
• W2066214356 hasConceptScore W2066214356C71240020 @default.
• W2066214356 hasConceptScore W2066214356C86803240 @default.
• W2066214356 hasConceptScore W2066214356C89423630 @default.
• W2066214356 hasConceptScore W2066214356C98274493 @default.
• W2066214356 hasIssue "8" @default.
• W2066214356 hasLocation W20662143561 @default.
• W2066214356 hasLocation W20662143562 @default.
• W2066214356 hasOpenAccess W2066214356 @default.
• W2066214356 hasPrimaryLocation W20662143561 @default.
• W2066214356 hasRelatedWork W10317223 @default.
• W2066214356 hasRelatedWork W1551171398 @default.
• W2066214356 hasRelatedWork W1946639121 @default.
• W2066214356 hasRelatedWork W2034138452 @default.
• W2066214356 hasRelatedWork W2112500437 @default.
• W2066214356 hasRelatedWork W2409850944 @default.
• W2066214356 hasRelatedWork W2500706580 @default.
• W2066214356 hasRelatedWork W3125301976 @default.
• W2066214356 hasRelatedWork W4285242151 @default.

• next